The UPMC Hillman Cancer Center Cancer Pharmacokinetics and Pharmacodynamics Facility (CPPF) provides accessible, economical, comprehensive, and state-of-the-art pharmacology research services that support preclinical and clinical research programs at UPMC Hillman Cancer Center and medical institutions nationwide.
Pharmacokinetic (PK) and pharmacodynamic (PD) activities are often pursued separately, yet each provides a complementary aspect of the processes involved in the interaction between drugs and targets. The CPPF is uniquely positioned to provide PK and PD capabilities to the research community in an integrated and coordinated fashion. The activities of the CPPF are well poised to bridge the divide between preclinical and clinical studies. The services provided by the CPPF leverage knowledge, insight, and pharmacokinetic and pharmacodynamic (PK/PD) analytical tools and expertise in order to optimally support preclinical and clinical projects.
Location & Hours of Operation
5117 Centre Avenue Suite G.28, Pittsburgh, PA 15213
| Self-Use | TBD |
| Assisted-Use | TBD |
Citation Information
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA047904 and the UPMC Hillman Cancer Center Cancer Pharmacokinetics and Pharmacodynamics Facility (RRID:SCR_025358).